Results 131 to 140 of about 380,048 (349)

Effect of Dyslipidaemia and Metabolic Function in Coronary Heart Disease with Type 2 Diabetes Mellitus - In Tertiary Care Center

Journal of Pharmacy and Bioallied Sciences
Introduction: T2DM is strongly associated with an increased prevalence of cardiovascular disease (CVD). It has been established that CVD is the main cause of mortality among patients with type 2 diabetes mellitus (T2DM) contributing to 80% of fatal ...
Akansha Singh, Ranjit S. Ambad, Roshan Kumar Jha   +2 more
doaj   +1 more source

Hyperlipidaemia elicits an atypical, T helper 1-like CD4⁺ T-cell response: a key role for very low-density lipoprotein. [PDF]

Eur Heart J Open, 2023
van Os BW, Vos WG, Bosmans LA, van Tiel CM, Lith SC, den Toom MS, Beckers L, Levels JHM, van Wouw SAE, Zelcer N, Zaal EA, Berkers CR, van der Lest CHA, Helms JB, Weber C, Atzler D, de Winther MPJ, Baardman J, Lutgens E.   +18 more
europepmc   +1 more source

Extracellular LCN2 Binding to 24p3R in Astrocytes Impedes α‐Synuclein Endocytosis in Parkinson's Disease

Advanced Science, EarlyView.
24p3R is an astrocytic receptor for α‐Syn uptake. When LCN2 is secreted from astrocytes, it binds to its receptor 24p3R in astrocytes and this binding impedes the α‐Syn PFF binding to 24p3R. This in turn inhibits 24p3R‐mediated α‐Syn PFF uptake and reduces the clearance of extracellular α‐Syn by astrocytes, which contributes to α‐Syn spread and ...
Ying‐Ying Jiao, Tian Tian, Zhu Zhu, Lei Cao, Yang Liu, Rui‐An Wang, Zhi‐Yong Zhou, Cong Wang, Ke‐Zhong Zhang, Xiao Lu, Wen‐Wei Yun, Ying‐Mei Lu, Gang Hu, Ren‐Hong Du, Ming Lu   +14 more
wiley   +1 more source

In vitro incorporation of cholesterol-14C in to very low density lipoprotein cholesteryl esters

, 1968
Yasuo Akanuma, John Glomset
openalex   +1 more source

Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease

Liver international (Print), 2016
Z. Jiang, E. Tapper, M. Connelly, C. Pimentel, L. Feldbrügge, Misung Kim, S. Krawczyk, N. Afdhal, S. Robson, M. Herman, J. Otvos, K. Mukamal, M. Lai   +12 more
semanticscholar   +1 more source

Soluble very low-density lipoprotein receptor (sVLDLR) inhibits fibrosis in neovascular age-related macular degeneration. [PDF]

FASEB J, 2021
Ma X, Takahashi Y, Wu W, Chen J, Dehdarani M, Liang W, Shin YH, Benyajati S, Ma JX.   +8 more
europepmc   +1 more source

Association of lipoprotein lipase with very low density lipoprotein remnants [PDF]

FEBS Letters, 1979
N. Matsuoka, Judith A.K. Harmony, Richard L. Jackson   +2 more
openaire   +3 more sources

Ligilactobacillus Murinus and Lactobacillus Johnsonii Suppress Macrophage Pyroptosis in Atherosclerosis through Butyrate‐GPR109A‐GSDMD Axis

Advanced Science, EarlyView.
Oral aspirin administration induces intestinal expansion of Lactobacillus murinus and Lactobacillus johnsonii, which suppresses the progression of atherosclerosis. This microbial expansion significantly enhances butyrate production by providing lactate as a metabolic substrate, thereby fostering the growth of butyrate‐producing bacteria. Butyrate plays
Rui Hua, Ning Ding, Yiming Hua, Xiaoke Wang, Yu Xu, Xiangrui Qiao, Xue Shi, Ting Bai, Ying Xiong, Xiaozhen Zhuo, Chong Fan, Juan Zhou, Yue Wu, Junhui Liu, Zuyi Yuan, Ting Li   +15 more
wiley   +1 more source

Characterization of very low density lipoprotein from Watanabe heritable hyperlipidemic rabbits.

Journal of Lipid Research, 1989
We investigated the properties of very low density lipoprotein (VLDL) from two types of Watanabe heritable hyperlipidemic (WHHL) rabbits: one with a high incidence of coronary atherosclerosis (type 1), and the other with a low incidence (type 2).
K Ishii, T Kita, M Yokode, N Kume, Y Nagano, H Otani, T Yamamura, S Murayama, Y Morimoto, Y Teranishi   +9 more
doaj  

Studies of the Proteins in Human Plasma Very Low Density Lipoproteins

, 1969
W. Virgil Brown, Robert I. Levy, Donald S. Fredrickson   +2 more
openalex   +1 more source